When it comes to the risk of structural valve deterioration, however, one treatment option clearly outperforms the other. 

In addition, the team reported, an EPA monotherapy appears to be more beneficial than a mix of EPA and DHA.

The risk of in-hospital mortality, for instance, increased considerably when patients underwent TAVR and a mitral procedure. 

Researchers explored the "prolonged physiological impact of COVID-19" in a research letter published in JAMA Network Open.

Researchers will provide a full breakdown of the study's findings in August. 

The algorithm measures the amount of fat surrounding a person's heart, using that information to create an accurate diabetes risk assessment. 

The new analysis, published in the Journal of the American Heart Association, examines the connection between CHD and stroke risk from multiple angles. 

The agency now recommends Aduhelm only for patients in the early stages of the disease, more closely aligning with the population tested during clinical trials.